Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Veracyte (VCYT) Shares Outstanding (Diluted Average) (2019 - 2025)

Veracyte (VCYT) has disclosed Shares Outstanding (Diluted Average) for 7 consecutive years, with $80.6 million as the latest value for Q4 2025.

  • Quarterly Shares Outstanding (Diluted Average) rose 3.08% to $80.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $80.6 million through Dec 2025, up 3.08% year-over-year, with the annual reading at $80.6 million for FY2025, 3.08% up from the prior year.
  • Shares Outstanding (Diluted Average) hit $80.6 million in Q4 2025 for Veracyte, up from $79.9 million in the prior quarter.
  • In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $80.6 million in Q4 2025 to a low of $63.3 million in Q1 2021.
  • Historically, Shares Outstanding (Diluted Average) has averaged $73.4 million across 5 years, with a median of $72.4 million in 2023.
  • Biggest five-year swings in Shares Outstanding (Diluted Average): soared 35.08% in 2021 and later increased 1.16% in 2023.
  • Year by year, Shares Outstanding (Diluted Average) stood at $67.9 million in 2021, then rose by 5.39% to $71.5 million in 2022, then grew by 1.53% to $72.6 million in 2023, then rose by 7.6% to $78.2 million in 2024, then grew by 3.08% to $80.6 million in 2025.
  • Business Quant data shows Shares Outstanding (Diluted Average) for VCYT at $80.6 million in Q4 2025, $79.9 million in Q3 2025, and $78.4 million in Q2 2025.